{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:26:51Z","timestamp":1790616411898,"version":"4.1.0"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T00:00:00Z","timestamp":1267142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Eur J Clin Invest 2010; 40 (3): 195\u2013202<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Background\u2002<\/jats:bold>\n                      Activation of the endothelin\u20101 (ET\u20101) pathway may be involved in hypoxia\u2010induced pulmonary vasoconstriction, increase in pulmonary pressure and high altitude pulmonary oedema. Thus, we investigated the effect of the ETA\/ETB receptor antagonist, bosentan, on pulmonary artery systolic pressure (PASP) in healthy subjects (\n                      <jats:italic>n<\/jats:italic>\n                      \u2003=\u200310).\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Design\u2002<\/jats:bold>\n                      We used a double\u2010blind, placebo\u2010controlled, randomized, cross\u2010over design to study the effects of a single oral dose of bosentan (250\u2003mg) on PASP after 90\u2010min\u2010exposure to normobaric hypoxia (FiO\n                      <jats:sub>2<\/jats:sub>\n                      \u2003=\u20030\u00b712). We measured PASP and cardiac output by echocardiography, systolic arterial blood pressure, arterial O\n                      <jats:sub>2<\/jats:sub>\n                      saturation (SaO\n                      <jats:sub>2<\/jats:sub>\n                      ), and blood gases at rest and during a sub\u2010maximal exercise.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Results\u2002<\/jats:bold>\n                      PASP in normoxia at rest was 23\u00b75\u2003\u00b1\u20032\u00b77 and during exercise 39\u00b78\u2003\u00b1\u200311\u00b76\u2003mmHg (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030\u00b70001). During the placebo period, hypoxia induced a significant decrease in SaO\n                      <jats:sub>2<\/jats:sub>\n                      , PaO\n                      <jats:sub>2<\/jats:sub>\n                      and PCO\n                      <jats:sub>2<\/jats:sub>\n                      and increase in pH. PASP at rest increased significantly: 32\u00b71\u2003\u00b1\u20033\u00b75\u2003mmHg (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030\u00b7001 vs. normoxia). Bosentan significantly blunted the hypoxia\u2010induced increase in PASP: bosentan: 27\u00b70\u2003\u00b1\u20033\u00b73\u2003mmHg,\n                      <jats:italic>P<\/jats:italic>\n                      \u2003=\u20030\u00b7002 vs. placebo at rest, but not during exercise: bosentan 39\u00b78\u2003\u00b1\u200311\u00b76 vs. placebo 43\u00b70\u2003\u00b1\u20038\u00b75\u2003mmHg, ns. Bosentan had no effect on the hypoxia\u2010induced changes in blood gases, or on cardiac output and systolic arterial blood pressure, which were not modified by hypoxia.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Conclusion\u2002<\/jats:bold>\n                      A single oral dose of bosentan blunted an acute hypoxia\u2010induced increase in PASP in healthy subjects, without altering cardiac output or systemic blood pressure.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1365-2362.2010.02254.x","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T03:54:10Z","timestamp":1267156450000},"page":"195-202","source":"Crossref","is-referenced-by-count":28,"title":["Endothelin receptors blockade blunts hypoxia\u2010induced increase in PAP in humans"],"prefix":"10.1111","volume":"40","author":[{"given":"I.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wuerzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010P.","family":"Richalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Peyrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,26]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.50.9.923"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107123450206"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91851-5"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12051181"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00073401"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200406-804OC"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-7-200610030-00007"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1995.268.2.H828"},{"key":"e_1_2_10_10_2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-3565(24)36446-8","article-title":"Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia\u2010induced pulmonary hypertension in the dog","volume":"280","author":"Willette RN","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.2.359"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.20.2665"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.605527"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2222"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012212"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2954"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0894-7317(89)80014-8"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02973-X"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2006.07.002"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1997.273.3.H1126"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00633-6"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.650994"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00075501"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1395"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90127-7"},{"key":"e_1_2_10_26_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/cs1040143","article-title":"ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin\u20101 in the splanchnic and renal circulation of healthy men","volume":"104","author":"Bohm F","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2010.02254.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2010.02254.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:05:27Z","timestamp":1739898327000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2010.02254.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,26]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1365-2362.2010.02254.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02254.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,26]]}}}